Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARL15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRKAR2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GART - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UQCRC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORD68 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRG1JP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
BET1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FMC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOSC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRG1KP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZCCHC14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WASL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2J1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKACB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on